Lantern Pharma Inc. Cash
Lantern Pharma Inc. (LTRN) had Cash of $2.38 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-05-15
- 2026-03-31: Cash $2.38M.
- 2025-12-31: Cash $2.88M.
- 2024-12-31: Cash $891.60K.
| Period end | Cash |
|---|---|
| 2026-03-31 | $2.38M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.88M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $891.60K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |